The RAS-MEK-ERK pathway in low-grade serous ovarian cancer. Stover EH, Lee EK, Shapiro GI, Brugge JS, et al. Gynecol Oncol 2025;200:22-32.

Read + Share

Amedeo Smart

Independent Medical Education

Stover EH, Lee EK, Shapiro GI, Brugge JS, et al. The RAS-MEK-ERK pathway in low-grade serous ovarian cancer. Gynecol Oncol 2025;200:22-32.
PMID: 40680327